Pesticide


As the only organization in the Northwest region to have obtained OECD GLP certification in the pesticide field, Guorui Yinuo passed the international assessment with a zero-defect record. Relying on its compliance credentials, comprehensive end-to-end technical capabilities, and high-standard laboratory platform, Guorui Yinuo provides global pesticide companies with integrated solutions spanning from research and development all the way through registration.

1. Core Advantages

Having obtained full OECD GLP certification, the test data are mutually recognized among all OECD member countries, eliminating the need for repeated testing and enabling registration submissions in mainstream markets such as the European Union and the United States—thus significantly shortening the cross-border registration process. At the same time, it is fully compliant with the GLP requirements of the Ministry of Agriculture and Rural Affairs, achieving “one-time testing, globally applicable,” and completely breaking down technical barriers to international trade.

2. Honorary Qualifications

Obtained the GLP certification from the Organisation for Economic Co-operation and Development (OECD) in August 2025.

3. Scope of Services

Focusing on the entire lifecycle of pesticide active ingredients and formulations, we integrate core technologies such as toxicity assessment, ecological safety evaluation, physicochemical analysis, and residue studies. Our services are tailored to meet the needs of various product categories, including small-molecule pesticides, biopesticides, and seed treatments. We provide seamless support—from candidate compound screening to submission of registration dossiers.

We have completed several pesticide trial projects, helping sponsor successfully register and submit applications to major markets such as the European Union and the United States.

More fields


Medicine

As an institution in Shaanxi Province that has obtained NMPA drug GLP certification and completed its qualification re-examination and scope expansion in 2024, Guorui Yinuo has built a “global + domestic” dual-compliance service capability in the pharmaceutical sector.

Veterinary Drug

The one-stop service platform for veterinary drugs—GLP/GCP—is a specialized service provider that offers an integrated solution—from non-clinical evaluation to clinical trials and registration submission—aligned with both the Ministry of Agriculture and Rural Affairs’ GLP/GCP standards for veterinary drugs and the international OECD GLP standards, covering the entire R&D process for veterinary pharmaceuticals. At its core, this platform addresses the key pain points faced by companies, including long R&D cycles, high compliance barriers, and fragmented resources.

Pesticide

As the only organization in the Northwest region to have obtained OECD GLP certification in the pesticide field, Guorui Yinuo passed the international assessment with a zero-defect record. Relying on its compliance credentials, comprehensive technological capabilities across the entire value chain, and high-standard laboratory platform, Guorui Yinuo provides integrated solutions for global pesticide companies—from research and development all the way through registration.

Chemical substances

Relying on the OECD GLP zero-defect certification qualification, chemical test data can be globally recognized and simultaneously comply with both domestic and international chemical regulatory requirements as well as relevant requirements of the Ministry of Ecology and Environment, efficiently supporting needs such as chemical registration and export declarations.

Guo Rui Xin Chuang

Shaanxi Guorui Xinchuang Medical Technology Co., Ltd. is an independent, third-party clinical preclinical safety evaluation research institution for medical devices. It was registered and established in June 2020 in the Airport New City and is currently the most comprehensive medical device safety evaluation institution in Northwest China. The company primarily provides product safety evaluation services to R&D enterprises specializing in Class II and Class III medical devices.

Hua Xin Yi Nuo

A full-process technology empowerment platform from target discovery to IND submission

Early Toxicity Prediction and Screening

Early toxicity screening is an essential and indispensable step in the new drug development process. Early termination of compounds that show no development potential can save sponsor substantial amounts of manpower, resources, and time. We offer sponsor comprehensive early toxicity screening services, including early genotoxicity assessment, early general toxicity assessment, and early reproductive and developmental toxicity assessment.

Pharmacodynamic studies

We are equipped with specialized instruments and devices, including flow cytometers, microplate readers, fluorescence microscopes, and PCR machines. These resources enable us to establish animal models for diseases affecting the tumor, cardiovascular, respiratory, metabolic, and urinary systems, and to conduct comprehensive and systematic preclinical studies on drug efficacy and mechanisms at multiple levels.

< 12 > proceed page